Nejdet,
2016 |
Retrospective cohort study |
Women from IVF Swedish clinics, from 2003 to 2012 |
Donor oocyte group consisted of 388 patients, 51 with
PE (13.14%). In the control group, 1,105/26,696 (4.14%) had PE. OR
9.059 (95% CI:5.518 to 14.874). Weight: 41.31. |
Van Dorp,
2014 |
Retrospective cohort
study |
Women from the Dutch
Perinatal Register, from 1992 to 2009 |
Study group consisted
of 61 patients with singleton pregnancies. 8 out of 61 had PE
(13.11%). The control group had 21/192 (10.94%) cases of PE. OR
1.238 (95% CI:0.502 to 3.053). Weight 12.47. |
Levron,
2014 |
Retrospective cohort study |
From 2005 to 2011. |
13 of 139 patients in the donor oocyte group had PE
(9.35%). In the autologous oocyte group, 6 of 126 had PE (4.76%). OR
1.988 (95% CI:0.782 to 5.052). Weight 11.67. |
Malchau,
2013 |
Retrospective cohort
study |
Women from the Danish
in vitro fertilization register, from 1995 to
2010. |
The donor oocyte group
included 215 patients and 21 cases of PE (9.76%). Control group had
316/9.833 (3.21%) with PE. OR 7.551 (95% CI:3.565 to 15.993). Weight
18.03. |
Stoop,
2012 |
Retrospective cohort study |
Matched pair-analysis for age, ethnicity, parity and
plurality from the Centre for Reproductive Medicine,Brussels. Data
obtained from 1999 to 2008. |
Donor oocyte had 15 of 148 pregnant women diagnosed
with PE (10.13%). Control group had 8 of 148 (5.4%) with PE. OR
1.930 (95% CI:0.825 to 4.515). Weight 14.07. |
Salha,
1999 |
Retrospective cohort
study |
Women from St. James's
University Hospital, Leeds(UK), from 1992 to 1997 |
Donor oocyte group had
3 of 22 patients diagnosed with PE (13.63%). In the control group,
only 1 pregnant woman of 26 was diagnosed with PE (3.8%). OR 3.508
(95% CI:0.459 to 26.781). Weight 2.46. |